The Research about Interaction of analgesic effect of Nalbuphine and Sufentanil After Laparoscopic Nephrectomy and Partial Nephrectomy.

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040719

Enrollment

Unknown

Registered

2020-12-08

Start date

2020-12-01

Completion date

Unknown

Last updated

2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Nephrectomy and Partial Nephrectomy.

Interventions

Nalbuphine Group:PCIA using Nalbuphine

Sufentanil Group:PCIA using Sufentanil

Nalbuphine and Sufentanil Group:PCIA using Nalbuphine and Sufentanil

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for surgical Laparoscopic Nephrectomy and Partial Nephrectomy; 2. ASA I~II; 3. Aged 40-70 years old; 4. BMI 18~25 kg/m2.

Exclusion criteria

Exclusion criteria: 1. Opioid allergy, recent use of opioids, opioid abuse; 2. Alcoholism and chronic pain; 3. History of respiratory, digestive and circulatory systems; 4. Mental illness; 5. Do not understand VAS score; 6. PCIA not accepted.

Design outcomes

Primary

Measure	Time frame
VAS score;Ramsay score;	—

Secondary

Measure	Time frame
Heart rate;Mean arterial pressure;SpO2;	—

Countries

China

Contacts

Public ContactYue Tian

Shengjing Hospital, China Medical University

2251900821@qq.com+86 18940259441

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026